Unknown

Dataset Information

0

COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy.


ABSTRACT: There is a high incidence of acute kidney injury with COVID-19 infections. The etiologies of acute kidney injury could be ischemic acute tubular necrosis or a complex process of complement activation leading to thrombotic microangiopathy. We present a case of 32-year-old Hispanic male with a history of heart transplant, admitted with COVID-19 and atypical hemolytic uremic syndrome, which was successfully treated with Eculizumab.

SUBMITTER: Gill J 

PROVIDER: S-EPMC8383924 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6794245 | biostudies-literature
| S-EPMC10808527 | biostudies-literature
| S-EPMC4835139 | biostudies-literature
| S-EPMC7543344 | biostudies-literature
| S-EPMC5466109 | biostudies-literature
| S-EPMC6409407 | biostudies-literature
| S-EPMC6933459 | biostudies-literature
| S-EPMC3863953 | biostudies-literature
| S-EPMC10065821 | biostudies-literature
| S-EPMC8280067 | biostudies-literature